China Pharma Holdings, Inc.
CPHI· NYSE
CPHIChina Pharma Holdings, Inc.
Filed Nov 14, 2012 · 10-Q · 45 days after period end · 0001010549-12-001213
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Revenue | $12.18M | $20.99M | $18.68M |
| Net Income | $1.30M | $3.29M | $5.91M |
| EPS Diluted | $0.03 | $0.11 | $0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
China Pharma Holdings, Inc. · CIK 1106644 · Engraved from SEC EDGAR
ended Sep 30, 2012 · filed Nov 14, 2012 · 45 d after period end
